Addressing Barriers to Achieving Cardiometabolic Disorders Prevention and Treatment Goals for PLWH in the SE US
Duke University · NCT05129345
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Observational
- Target enrollment
- 150
- US sites recruiting
- 2
- Study start
- June 7, 2022
- Record last updated
- July 24, 2025
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
This study has 3 aims. Aim 1: Identify social determinants of cardiometabolic health and determine facilitators and modifiable barriers in achieving treatment goals.
Aim 2: Assess PLWH knowledge, skills, and confidence for self-management of cardiometabolic disorders.
Aim 3: Tailor a self-management support and education intervention with stakeholder input to address barriers to achieving treatment goals for cardiometabolic disorders in PLWH at the study sites.
Conditions: Hypertension; Dyslipidemias; Type 2 Diabetes; HIV-1-infection
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
Aims 1 and 2
- People living with HIV who are at least 35 years of age and who have one or more of the following conditions: hypertension, dyslipidemia, or type 2 diabetes.
Aim 3
- Participants recruited from the participating clinics and community based organizations and may include, HIV providers, nurses, pharmacists, people living with HIV who have cardiometabolic disorders, and representatives of the community advisory boards, and any other key stakeholders. Age 18 or older.
Exclusion Criteria
- Those who don't understand English and those who are blind.
Recruiting US locations
Duke University - Charlotte Study Sites
Charlotte, NC 28205
Site contact: Lalia Victoria, BA, MSW · 704-641-0772 · lalia.victoria@duke.edu
Duke University - Duke Study Site
Durham, NC 27710
Site contact: Laura Farrow, BA · 919-668-0176 · laura.farrow@duke.edu
Study contacts (from the official record)
- Stuart T Carr, BA · 919 668-4849 · stuart.carr@duke.edu
- Charles Muiruri, PhD · 919 660-3212 · charles.muiruri@duke.edu
Similar studies in North Carolina
All diabetes studies in North Carolina →- RecruitingPhase 1Overnight stay mentioned
A Study of GNTI-122 in Adults Recently Diagnosed With T1D
GentiBio, Inc
- Location
- Chapel Hill, NC + 8 other US sites
- Eligibility basics
- Ages 18–55
- RecruitingHealthy volunteersPhase 1
Role of Alpha-to-beta Cell Communication to Adapt Insulin Secretion to Insulin Resistance.
David D'Alessio, M.D.
- Location
- Durham, NC
- Eligibility basics
- Ages 18–60
- RecruitingHealthy volunteersPhase 3
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics
- Location
- Charlotte, NC + 55 other US sites
- Eligibility basics
- Ages 18–79
- RecruitingHealthy volunteers
Assessment of AI Program 'DRISTi' as a Screening Tool
Artelus AI
- Location
- Oxford, NC + 1 other US site
- Eligibility basics
- Ages 21+